With the “gym,” Insilico is now targeting other biotech and pharmaceutical companies, offering to train new AI models for them.
Transformer on MSN
Teaching AI to learn
AI"s inability to continually learn remains one of the biggest problems standing in the way to truly general purpose models.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results